3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.

Current drug targets. CNS and neurological disorders

Volumn 2, Issue 2, 2003, Pages 143-148

  Burke, W J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETALDEHYDE; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,4-DIHYDROXYPHENYLACETALDEHYDE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; METHODOLOGY; PARKINSON DISEASE; REVIEW;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 0037844598     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007033482913     Document Type: Review

References (64)